Gordon P H, Cheng B, Katz I B, Mitsumoto H, Rowland L P
Department of Neurology, Columbia University, New York, NY, USA.
Neurology. 2009 Jun 2;72(22):1948-52. doi: 10.1212/WNL.0b013e3181a8269b.
To determine how clinical features at the first evaluation and in follow-up can be used to suggest a diagnostic outcome for patients with only upper motor neuron (UMN) signs at disease onset.
We reviewed the records of 34 patients (9 primary lateral sclerosis [PLS], 15 UMN-dominant amyotrophic lateral sclerosis [ALS], and 10 randomly selected control patients with ALS) seen in 1984-2007. Analysis of variance F tests for continuous variables and chi2 tests for categorical variables analyzed differences in baseline data among the diagnostic categories. Linear and generalized mixed effects models assessed the relation between examination data and diagnostic group over time.
At first examination, the lowest score of the weakest muscle (p < 0.001), the site of onset (p = 0.041), and time to evaluation (p = 0.05) discriminated between eventual diagnostic group; patients with PLS were stronger, slower in progressing, and more likely to have limb onset than the other groups. Strength < or = 4 on any muscle was associated with the diagnosis of ALS (p = 0.0001), but not PLS. Across all visits, muscle strength (p = 0.003), ALS Functional Rating Scale score (p = 0.009), and vital capacity (p = 0.026) predicted group assignment. UMN-dominant and ALS groups had more weight loss (p = 0.004), even when controlled for dysphagia (p = 0.021) and muscle atrophy (p = 0.009), and patients with ALS were more likely to have hyporeflexia (p = 0.001).
Features at baseline most suggestive of eventual lower motor neuron signs were focal muscle weakness or bulbar onset. Later, weight loss, reduced forced vital capacity, and limb weakness predicted lower motor neuron dysfunction. We suggest that patients with only upper motor neuron signs have periodic evaluations of strength, weight, forced vital capacity, Amyotrophic Lateral Sclerosis Functional Rating Scale score, and EMG, because a change in any can signal the imminent development of lower motor neuron signs.
确定首次评估及随访时的临床特征如何用于提示疾病起病时仅有上运动神经元(UMN)体征患者的诊断结果。
我们回顾了1984年至2007年期间诊治的34例患者的记录(9例原发性侧索硬化症[PLS]、15例UMN为主型肌萎缩侧索硬化症[ALS]以及10例随机选取的ALS对照患者)。对连续变量采用方差分析F检验,对分类变量采用卡方检验,分析各诊断类别间基线数据的差异。线性和广义混合效应模型评估随时间推移检查数据与诊断组之间的关系。
首次检查时,最弱肌肉的最低评分(p<0.001)、起病部位(p = 0.041)以及评估时间(p = 0.05)可区分最终诊断组;PLS患者比其他组更强壮、进展更慢且更可能以肢体起病。任何肌肉力量≤4与ALS诊断相关(p = 0.0001),但与PLS无关。在所有就诊中,肌肉力量(p = 0.003)、ALS功能评定量表评分(p = 0.009)和肺活量(p = 0.026)可预测分组。即使在控制吞咽困难(p = 0.021)和肌肉萎缩(p = 0.009)后,UMN为主型和ALS组仍有更多体重减轻(p = 0.004),且ALS患者更可能有反射减退(p = 0.001)。
基线时最提示最终下运动神经元体征的特征是局灶性肌肉无力或延髓起病。之后,体重减轻、用力肺活量降低和肢体无力提示下运动神经元功能障碍。我们建议仅有上运动神经元体征的患者定期评估力量、体重、用力肺活量、肌萎缩侧索硬化症功能评定量表评分和肌电图,因为其中任何一项的变化都可能预示下运动神经元体征即将出现。